Congenital Platelets Abnormality clinical trials at UC Health
1 research study open to new patients

• Clinical Performance Evaluation of T-TAS 01 PL Chip

  open to eligible people ages 21 years and up

  This study will measure primary hemostatic ability using the T-TAS 01 System with PL chip, with a comparison to clinical truth.

  at UCSF

Last updated: February 20, 2019